1. Home
  2. AXR vs FATE Comparison

AXR vs FATE Comparison

Compare AXR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$22.94

Market Cap

132.0M

Sector

Real Estate

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.31

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
FATE
Founded
1961
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.0M
125.6M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
AXR
FATE
Price
$22.94
$2.31
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$30.00
$4.10
AVG Volume (30 Days)
7.4K
1.2M
Earning Date
03-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.88
EPS
1.91
N/A
Revenue
$12,831,000.00
$6,646,000.00
Revenue This Year
$10.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$0.94
52 Week High
$29.01
$3.23

Technical Indicators

Market Signals
Indicator
AXR
FATE
Relative Strength Index (RSI) 46.47 41.80
Support Level $21.68 $2.27
Resistance Level $23.52 $2.88
Average True Range (ATR) 0.53 0.13
MACD 0.07 -0.01
Stochastic Oscillator 39.01 28.21

Price Performance

Historical Comparison
AXR
FATE

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: